These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 16974073

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M, Franke S, Wolf G, Brandstädt A, Ott U, Gerth J, Hunsicker LG, Stein G, Collaborative Study Group.
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products.
    Zheng F, He C, Cai W, Hattori M, Steffes M, Vlassara H.
    Diabetes Metab Res Rev; 2002 Oct; 18(3):224-37. PubMed ID: 12112941
    [Abstract] [Full Text] [Related]

  • 5. Renoprotective antioxidant effect of alagebrium in experimental diabetes.
    Park J, Kwon MK, Huh JY, Choi WJ, Jeong LS, Nagai R, Kim WY, Kim J, Lee GT, Lee HB, Ha H.
    Nephrol Dial Transplant; 2011 Nov; 26(11):3474-84. PubMed ID: 21478303
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Renoprotective effects of a novel inhibitor of advanced glycation.
    Forbes JM, Soulis T, Thallas V, Panagiotopoulos S, Long DM, Vasan S, Wagle D, Jerums G, Cooper ME.
    Diabetologia; 2001 Jan; 44(1):108-14. PubMed ID: 11206401
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetes.
    Coughlan MT, Forbes JM.
    Am J Nephrol; 2011 Jan; 34(1):9-17. PubMed ID: 21654162
    [Abstract] [Full Text] [Related]

  • 12. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy.
    Tan AL, Sourris KC, Harcourt BE, Thallas-Bonke V, Penfold S, Andrikopoulos S, Thomas MC, O'Brien RC, Bierhaus A, Cooper ME, Forbes JM, Coughlan MT.
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F763-70. PubMed ID: 20015941
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic effect of combination of alagebrium (ALT-711) and sildenafil on erectile function in diabetic rats.
    Gurbuz N, Sagdic G, Sanli A, Ciftcioglu A, Bassorgun I, Baykal A, Usta MF.
    Int J Impot Res; 2012 Mar; 24(3):114-21. PubMed ID: 22205245
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products.
    Sebeková K, Gazdíková K, Syrová D, Blazícek P, Schinzel R, Heidland A, Spustová V, Dzúrik R.
    J Hum Hypertens; 2003 Apr; 17(4):265-70. PubMed ID: 12692571
    [Abstract] [Full Text] [Related]

  • 16. Beneficial effects of phlorizin on diabetic nephropathy in diabetic db/db mice.
    Pei F, Li BY, Zhang Z, Yu F, Li XL, Lu WD, Cai Q, Gao HQ, Shen L.
    J Diabetes Complications; 2014 Apr; 28(5):596-603. PubMed ID: 24927646
    [Abstract] [Full Text] [Related]

  • 17. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R, Futterweit S, Valderrama E, Tarectecan AA, Bylander JE, Bond JS, Trachtman H.
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of eparlestat on plasma levels of advanced glycation end products in patients with type 2 diabetes.
    Nakamura N, Yamazaki K, Satoh A, Urakaze M, Kobayashi M, Yamabe H, Osawa H, Shirato K, Sugawara T, Nakamura M, Tamura M, Okumura K.
    In Vivo; 2003 Oct; 17(2):177-80. PubMed ID: 12792982
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM.
    Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.